Emergent BioSolutions Inc. (0IGA.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 661.26M |
| Enterprise Value | 1.05B |
| P/E Ratio | -1.73 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 0.4 |
| Price/Book Ratio | 0.9 |
| Enterprise/Revenue | 0.97 |
| Enterprise/EBITDA | -31.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.23 |
| Operating Margin | -0.07 |
AD
Management Effectiveness
| Return On Assets | -0.16 |
| Return On Equity | -0.36 |
Income Statement
| Revenue | 742.9M |
| Revenue/Share | 14.93 |
| Gross Profit | 361.2M |
| EBITDA | 217.9M |
| Net Income | 52.6M |
| Diluted EPS | 0.93 |
Balance Sheet
| Total Cash | 140.9M |
| Total Cash/Share | 2.71 |
| Total Debt | 588.2M |
| Total Debt/Equity | 1.7 |
| Current Ratio | 5.42 |
| Book Value Per Share | 6.62 |
Price History
| 52-Week Change | -26.42 |
| 52-Week High | 13.42 |
| 52-Week Low | 1.48 |
| Moving Average 50 Days | 2.24 |
| Moving Average 200 Days | 4.13 |
Statistics
| Average Volume | 19,429 |
| Shares Outstanding | 52.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
